|
1
|
Wilson C: Reproductive endocrinology:
AS101 might prevent chemotherapy-induced infertility. Nat Rev
Endocrinol. 9:4412013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rowe AM, St Leger AJ, Jeon S, Dhaliwal DK,
Knickelbein JE and Hendricks RL: Herpes keratitis. Prog Retin Eye
Res. 32:88–101. 2013. View Article : Google Scholar
|
|
3
|
Rozenberg F, Deback C and Agut H: Herpes
simplex encephalitis: From virus to therapy. Infect Disord Drug
Targets. 11:235–250. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Taylor TJ, Brockman MA, McNamee EE and
Knipe DM: Herpes simplex virus. Front Biosci. 7:d752–d764. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Piret J and Boivin G: Resistance of herpes
simplex viruses to nucleoside analogues: Mechanisms, prevalence,
and management. Antimicrob Agents Chemother. 55:459–472. 2011.
View Article : Google Scholar :
|
|
6
|
Zhang Y, But PP, Ooi VE, Xu HX, Delaney
GD, Lee SH and Lee SF: Chemical properties, mode of action, and in
vivo anti-herpes activities of a lignin-carbohydrate complex from
Prunella vulgaris. Antiviral Res. 75:242–249. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yarmolinsky L, Zaccai M, Ben-Shabat S,
Mills D and Huleihel M: Antiviral activity of ethanol extracts of
Ficus binjamina and Lilium candidum in vitro. N Biotechnol.
26:307–313. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bernstein DI, Miller RL and Harrison CJ:
Effects of therapy with an immunomodulator (imiquimod, R-837) alone
and with acyclovir on genital HSV-2 infection in guinea-pigs when
begun after lesion development. Antiviral Res. 20:45–55. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Abad MJ, Guerra JA, Bermejo P, Irurzun A
and Carrasco L: Search for antiviral activity in higher plant
extracts. Phytother Res. 14:604–607. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hirokawa D, Woldow A, Lee SN and Samie F:
Treatment of recalcitrant herpes simplex virus with topical
imiquimod. Cutis. 88:276–277. 2011.
|
|
11
|
Albeck A, Weitman H, Sredni B and Albeck
M: Tellurium compounds: Selective Inhibition of cysteine proteases
and model reaction with thiols. Inorg Chem. 37:1704–1712. 1998.
View Article : Google Scholar
|
|
12
|
Halperin-Sheinfeld M, Gertler A, Okun E,
Sredni B and Cohen HY: The Tellurium compound, AS101, increases
SIRT1 level and activity and prevents type 2 diabetes. Aging
(Albany NY). 4:436–447. 2012.
|
|
13
|
Sredni B, Geffen-Aricha R, Duan W, Albeck
M, Shalit F, Lander HM, Kinor N, Sagi O, Albeck A, Yosef S, et al:
Multifunctional tellurium molecule protects and restores
dopaminergic neurons in Parkinson’s disease models. FASEB J.
21:1870–1883. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sredni B, Gal R, Cohen IJ, Dazard JE,
Givol D, Gafter U, Motro B, Eliyahu S, Albeck M, Lander HM, et al:
Hair growth induction by the Tellurium immunomodulator AS101:
Association with delayed terminal differentiation of follicular
keratinocytes and ras-dependent up-regulation of KGF expression.
FASEB J. 18:400–402. 2004.
|
|
15
|
Sredni B, Rosenthal-Galili Z, Michlin H,
Sobelman D, Seger Y, Blagerman S, Kalechman Y and Rager-Zisman B:
Restoration of murine cytomegalovirus (MCMV) induced
myelosuppression by AS101. Immunol Lett. 43:159–165. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vonsover A, Loya S, Sredni B, Albeck M,
Gotlieb-Stematsky T, Araf O and Hizi A: Inhibition of the reverse
transcriptase activity and replication of human immunodeficiency
virus type 1 by AS101 in vitro. AIDS Res Hum Retroviruses.
8:613–623. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Indenbaum V, Bin H, Makarovsky D, Weil M,
Shulman LM, Albeck M, Sredni B and Mendelson E: In vitro and in
vivo activity of AS101 against West Nile virus (WNV). Virus Res.
166:68–76. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Friedman M, Bayer I, Letko I, Duvdevani R,
Zavaro-Levy O, Ron B, Albeck M and Sredni B: Topical treatment for
human papillomavirus-associated genital warts in humans with the
novel tellurium immunomodulator AS101: Assessment of its safety and
efficacy. Br J Dermatol. 160:403–408. 2009. View Article : Google Scholar
|
|
19
|
Cantatore A, Randall SD, Traum D and Adams
SD: Effect of black tea extract on herpes simplex virus-1 infection
of cultured cells. BMC Complement Altern Med. 13:1392013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Filén F, Strand A, Allard A, Blomberg J
and Herrmann B: Duplex real-time polymerase chain reaction assay
for detection and quantification of herpes simplex virus type 1 and
herpes simplex virus type 2 in genital and cutaneous lesions. Sex
Transm Dis. 31:331–336. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Snoeck R: Antiviral therapy of herpes
simplex. Int J Antimicrob Agents. 16:157–159. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wilson SS, Fakioglu E and Herold BC: Novel
approaches in fighting herpes simplex virus infections. Expert Rev
Anti Infect Ther. 7:559–568. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Koyama AH and Uchida T: Quantitative
studies on the maturation process of herpes simplex virus type 1 in
Vero cells. Virus Res. 10:281–285. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Norais N, Tang D, Kaur S, Chamberlain SH,
Masiarz FR, Burke RL and Marcus F: Disulfide bonds of herpes
simplex virus type 2 glycoprotein gB. J Virol. 70:7379–7387.
1996.PubMed/NCBI
|
|
25
|
Foster TP and Kousoulas KG: Genetic
analysis of the role of herpes simplex virus type 1 glycoprotein K
in infectious virus production and egress. J Virol. 73:8457–8468.
1999.PubMed/NCBI
|
|
26
|
Foster TP, Chouljenko VN and Kousoulas KG:
Functional and physical interactions of the herpes simplex virus
type 1 UL20 membrane protein with glycoprotein K. J Virol.
82:6310–6323. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gianni T and Campadelli-Fiume G:
αVβ3-integrin relocalizes nectin1 and routes herpes simplex virus
to lipid rafts. J Virol. 86:2850–2855. 2012. View Article : Google Scholar :
|
|
28
|
Parry C, Bell S, Minson T and Browne H:
Herpes simplex virus type 1 glycoprotein H binds to alphavbeta3
integrins. J Gen Virol. 86:7–10. 2005. View Article : Google Scholar
|
|
29
|
Mingo RM, Han J, Newcomb WW and Brown JC:
Replication of herpes simplex virus: Egress of progeny virus at
specialized cell membrane sites. J Virol. 86:7084–7097. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ikeda K, Yamasaki H, Minami S, Suzuki Y,
Tsujimoto K, Sekino Y, Irie H, Arakawa T and Koyama AH: Arginine
inactivates human herpesvirus 2 and inhibits genital herpesvirus
infection. Int J Mol Med. 30:1307–1312. 2012.PubMed/NCBI
|
|
31
|
Daniel-Hoffmann M, Albeck M, Sredni B and
Nitzan Y: A potential antimicrobial treatment against
ESBL-producing Klebsiella pneumoniae using the tellurium compound
AS101. Arch Microbiol. 191:631–638. 2009. View Article : Google Scholar : PubMed/NCBI
|
